News | July 30, 2024
Pfizer Ltd. posts Q1 FY25 PAT at Rs. 150.71 Cr
Pfizer Ltd. has reported total income of Rs. 604.70 crores during the period ended June 30, 2024
Pfizer Ltd. has reported total income of Rs. 604.70 crores during the period ended June 30, 2024
Report highlights significant improvements in adolescent well-being in India
Integrated Disease Surveillance Programme (IDSP) strengthened to improve disease surveillance and rapid data reporting
Dr. Reddy's Laboratories has reported total income of Rs. 7,672.7 crores during the period ended June 30, 2024
The inspection scope included 6 separate Biologics manufacturing units comprising 4 Drug Substance and 2 Drug Product manufacturing plants
Giroctocogene fitelparvovec study meets primary and key secondary objectives of superiority compared to prophylaxis
A one-time dose of DURVEQTIX has reduced bleeds post-treatment compared to standard of care with a median annualized bleed rate (ABR) of zero bleeds (range 0 to 9.9)
Glenmark Life Sciences has reported total income of Rs. 594.109 crores during the period ended June 30, 2024
This strategic move aims to make Cupid's high-quality products more accessible to consumers nationwide
Leqselvi delivered statistically significant efficacy across two Phase 3 clinical trials
Subscribe To Our Newsletter & Stay Updated
